Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Meta shares popped on news that the company is building out a new cloud business. The company will sell its excess computing power to outside customers, CNBC confirmed. The new business is a welcome ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

Under the new initiative, Chipmaker Nvidia aims to expand infrastructure access for emerging enterprises. Two initial partners are offering potential access to more than 200,000 GPUs, including via an ...

Meta has spent billions of dollars developing AI and building out data centers to support it. But now, the company may be preparing to put those data centers to a more immediately profitable purpose.

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

New first-of-its-kind program in Illinois will support grid affordability and reliability while allowing customers with battery storage to earn incentives for participating ComEd today announced that ...

Recursion Pharmaceuticals leverages an artificial intelligence platform to decode biology and automate the drug discovery process. Summit Therapeutics is focused on its lead oncology candidate, ...

According to Bloomberg, the effort is internally called Meta Compute, and the company is debating two approaches: giving developers access to AI models hosted on Meta's infrastructure, or selling raw ...